Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05781295 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Multicentre Randomised Study Comparing a Taurolidine Lock and a Standard Saline Lock in Paediatric Oncology

Study acronym: PEDIALOCK
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site contacts updated at 1 of 5 sitesv9
  2. Re-verified, no change to tracked fieldsv8
  3. Site details revised at 5 of 5 sitesv7
  4. Re-verified, no change to tracked fieldsv6
  5. Primary and study completion dates: Apr 19, 2026 to Jul 23, 2028
    • Eligibility criteria expanded, about 16 words
    • Site details revised at 1 of 5 sites
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 4 to 5
    • Primary and study completion dates: Apr 13, 2026 to Apr 19, 2026
    • Start date changed from estimate of Jan 10, 2024 to Jan 19, 2024
    v4
  2. Primary and study completion dates: Dec 2027 to Apr 13, 2026
    • Start date: Oct 2023 to Jan 10, 2024
    v3
  3. Start date: Jun 2023 to Oct 2023
    • Study title shortened, about 8 words
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Institut Curie
43 trials monitored
See 1 trial at risk
Interest of a Taurolidine lock at each catheter closure in the primary prevention of catheter-related endoluminal infection in paediatric oncology. Multicentric, controlled, randomized and double-blind label study.
Trial Details
NCT Number NCT05781295
Lead Sponsor Institut Curie
Conditions
(from sponsor)		 Children, Medical Device, Primary Prevention, Oncology
Related terms Neoplasms
Enrollment 148 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov